ROI-NJ: BD’s new Onclarity HPV test greatly improves standard of care for women
Molly Broache, Associate Director, Medical Affairs for US IDS explains how the BD Onclarity™ HPV Assay positively impacts public health by providing a more precise estimate of a woman’s risk of cervical precancer and cancer.